To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC93TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
318 supporting clones for gene CCDC93 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP239543 Liver .a 1 to 606 2 to 601       601/601
(100 %)
9 diff
(98.6 %id)
DB074797 testis .a 1 to 545 2 to 545   capped   544/544
(100 %)
5 diff
(99.1 %id)
DB079499 testis .a 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
DB084596 testis .a 1 to 556 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BP213810 cerebrum .a 17 to 587 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
DA176662 amygdala .a 21 to 551 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DB022149 testis .a 21 to 487 2 to 468   capped   467/467
(100 %)
2 diff
(99.6 %id)
DB272006 uterus .a 21 to 559 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BC028609 testis .a 24 to 2810 1 to 2784 Y39H R213C available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2784/2786
(99 %)
8 diff
(99.8 %id)
BG723443 testis .a 24 to 689 1 to 666       664/666
(99 %)
15 diff
(97.8 %id)
TI_44349109   .a 41 to 825 74 to 860       787/870
(90 %)
17 diff
(98.1 %id)
AL534313 brain, fetal brain .a 42 to 1035 1 to 991       991/1002
(98 %)
53 diff
(94.8 %id)
NM_019044.3   .a 42 to 6835 1 to 6794 exact RefSeq,   6794/6794
(100 %)
1 diff
(100.0 %id)
BI560873 testis .a 48 to 825 1 to 780       780/790
(98 %)
17 diff
(97.9 %id)
BG719989 testis .a 49 to 792 1 to 746       746/750
(99 %)
11 diff
(98.6 %id)
BG926695 cartilage .a 53 to 660 78 to 685       608/637
(95 %)
13 diff
(98.0 %id)
AB209993 brain .a 81 to 6826 1 to 6744 R179C tiling clone,   6744/6744
(100 %)
14 diff
(99.8 %id)
BP277852   .a 82 to 666 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
AL520450 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 84 to 1055 1 to 974       974/974
(100 %)
6 diff
(99.4 %id)
BG341881 B-cells, primary B-cells from tonsils (cell line) .a 85 to 796 1 to 712   available from MGC,   712/775
(91 %)
14 diff
(98.2 %id)
BC012052 Primary B-Cells from Tonsils .a 86 to 1895 1 to 1810   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1810/1832
(98 %)
0 diff
(100 %id)
DA688302   .a 91 to 645 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AK290722 lung .a 93 to 2123 1 to 2031 exact tiling clone,   2031/2031
(100 %)
0 diff
(100 %id)
DA316450 hippocampus .a 94 to 660 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA593967 lung .a 94 to 641 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA595160 lung .a 94 to 680 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DB126372 thymus .a 94 to 653 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB161008 thymus .a 94 to 685 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
BP202603 amygdala .a 110 to 691 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BC093018 Placenta, pre-eclamptic .a 110 to 2812 1 to 2703 R179C AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2703/2703
(100 %)
3 diff
(99.9 %id)
CB997636 placenta, pre-eclamptic placenta .a 110 to 875 28 to 795       768/796
(96 %)
13 diff
(98.4 %id)
CB993194 placenta, pre-eclamptic placenta .a 110 to 898 28 to 817       790/817
(96 %)
16 diff
(98.1 %id)
CB993749 placenta, pre-eclamptic placenta .a 110 to 756 28 to 680       653/833
(78 %)
15 diff
(98.2 %id)
CB998178 placenta, pre-eclamptic placenta .a 110 to 785 28 to 714       687/809
(84 %)
29 diff
(96.5 %id)
CB998169 placenta, pre-eclamptic placenta .a 110 to 857 28 to 782       755/783
(96 %)
16 diff
(98.0 %id)
CB997898 placenta, pre-eclamptic placenta .a 110 to 788 28 to 714       687/788
(87 %)
19 diff
(97.6 %id)
DA274221 corpus callosum .a 113 to 670 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BI914333 brain .a 130 to 884 1 to 757       757/757
(100 %)
10 diff
(98.7 %id)
TI_57242937   .a 130 to 884 68 to 824       757/824
(91 %)
13 diff
(98.5 %id)
CN343701 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 135 to 502 1 to 369       369/369
(100 %)
6 diff
(98.4 %id)
AK057926   .a 139 to 1892 1 to 1754   available from FLJ,   1754/1754
(100 %)
2 diff
(99.9 %id)
BP326569 prostata .a 141 to 722 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
AK025611   .a 232 to 2409 1 to 2178   available from FLJ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2178/2178
(100 %)
1 diff
(100.0 %id)
AI902949 breast .a 415 to 623 1 to 209       209/209
(100 %)
3 diff
(98.6 %id)
DB055310 testis .a 540 to 1084 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BX488029   .a 687 to 807 29 to 150       122/150
(81 %)
1 diff
(99.4 %id)
BF832147 head_neck .a 967 to 1571 1 to 601       601/601
(100 %)
8 diff
(98.7 %id)
AK001858 placenta .a 1206 to 2811 1 to 1606   available from FLJ,   1606/1606
(100 %)
1 diff
(100.0 %id)
AU135587 placenta .a 1207 to 1892 2 to 689   capped   688/713
(96 %)
7 diff
(99.1 %id)
CN343700 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1214 to 1718 1 to 505       505/505
(100 %)
0 diff
(100 %id)
FN117533 breast carcinoma .a 1338 to 1432 93 to 1     Submitted on the opposite strand 93/93
(100 %)
2 diff
(97.9 %id)
BP375302 uterus .a 1362 to 1925 1 to 564       564/564
(100 %)
0 diff
(100 %id)
AL561878 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1520 to 2389 876 to 1       876/876
(100 %)
7 diff
(99.3 %id)
CB250622 Human Lung Epithelial cells, lung .a 1571 to 1913 347 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 343/362
(94 %)
5 diff
(98.7 %id)
BM831328 stomach .a 1733 to 2338 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM833479 stomach .a 1733 to 2040 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BM822389 stomach .a 1763 to 2074 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
BU508060 leiomyosarcoma, uterus .a 1829 to 2406 11 to 588   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 578/588
(98 %)
6 diff
(99.0 %id)
BE774662 uterus .a 1866 to 2362 495 to 1       495/495
(100 %)
8 diff
(98.4 %id)
TI_149277182   .a 1890 to 2409 600 to 81   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 520/983
(52 %)
3 diff
(99.7 %id)
BU677547 lung, Primary Lung Epithelial Cells .a 1890 to 2409 538 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 520/521
(99 %)
3 diff
(99.5 %id)
CN343699 embryonic stem cells, cell lines H1, H7, andH9 .a 1935 to 2513 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
AI587324 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2025 to 2407 385 to 3       383/385
(99 %)
0 diff
(100 %id)
AW879503 ovary .a 2043 to 2264 1 to 220       220/220
(100 %)
2 diff
(99.1 %id)
BE832755 ovary .a 2043 to 2270 1 to 226       226/233
(96 %)
4 diff
(98.3 %id)
AW879305 ovary .a 2050 to 2270 1 to 219       219/234
(93 %)
11 diff
(95.3 %id)
BU618563 Cell Line, Chondrosarcoma .a 2153 to 2811 676 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 658/658
(100 %)
1 diff
(99.9 %id)
CA308084 Alveolar Macrophage, lung .a 2178 to 2812 652 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 634/634
(100 %)
1 diff
(99.9 %id)
BG827861 muscle, rhabdomyosarcoma .a 2191 to 2899 1 to 704       704/704
(100 %)
11 diff
(98.5 %id)
BG829197 muscle, rhabdomyosarcoma .a 2192 to 2859 2 to 680       679/680
(99 %)
6 diff
(99.2 %id)
BQ776337 Bone, Human Chondrosarcoma Cell Line .a 2225 to 2811 608 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 590/590
(100 %)
6 diff
(99.0 %id)
AU156153 placenta .a 2291 to 2811 521 to 1       521/525
(99 %)
4 diff
(99.3 %id)
AA621959 colon, colon tumor RER+ .a 2301 to 2811 511 to 1       511/511
(100 %)
0 diff
(100 %id)
AA885073 pooled .a 2314 to 2806 498 to 6       493/498
(98 %)
0 diff
(100 %id)
AI339390 pooled germ cell tumors .a 2348 to 2812 465 to 1       465/465
(100 %)
0 diff
(100 %id)
CN343698 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2366 to 3101 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
CF786072 mixed .a 2425 to 3212 1 to 784       784/833
(94 %)
6 diff
(99.3 %id)
CK000766 mixed .a 2432 to 3217 9 to 794       786/794
(98 %)
6 diff
(99.3 %id)
AA865961 pooled germ cell tumors .a 2460 to 2811 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AW511596 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2570 to 2812 257 to 15   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 243/243
(100 %)
1 diff
(99.6 %id)
BX472657   .a 2645 to 3223 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CF995840 mixed .a 2921 to 3695 1 to 774       774/778
(99 %)
9 diff
(98.9 %id)
BI917767 brain .a 3084 to 3871 1 to 794       794/795
(99 %)
15 diff
(98.2 %id)
TI_57243885   .a 3084 to 3871 31 to 824       794/825
(96 %)
15 diff
(98.2 %id)
BQ441886 large cell carcinoma, lung .a 3106 to 3935 12 to 849   tiling clone,   838/874
(95 %)
18 diff
(98.0 %id)
BE166448 head_neck .a 3161 to 3713 554 to 2     Submitted on the opposite strand 553/563
(98 %)
0 diff
(100 %id)
BE166457 head_neck .a 3180 to 3735 554 to 1     Submitted on the opposite strand 554/554
(100 %)
2 diff
(99.7 %id)
BE166447 head_neck .a 3247 to 3703 457 to 1     Submitted on the opposite strand 457/457
(100 %)
2 diff
(99.6 %id)
BM551498 astrocytoma grade IV, cell line, brain .a 3413 to 4354 1 to 951       951/1110
(85 %)
26 diff
(97.7 %id)
EH339777   .a 3425 to 3497 1 to 73       73/73
(100 %)
0 diff
(100 %id)
BM021038 astrocytoma grade IV, cell line, brain .a 3429 to 3912 20 to 514       495/965
(51 %)
35 diff
(96.4 %id)
TI_59391232   .a 3429 to 3912 20 to 514       495/965
(51 %)
35 diff
(96.4 %id)
BQ371842 prostate_normal .a 3713 to 4103 78 to 463       386/465
(83 %)
15 diff
(96.8 %id)
AL705182 human skeletal muscle .a 3737 to 4258 1 to 527       527/527
(100 %)
8 diff
(98.5 %id)
BQ549954 insulinoma, Pancreas .a 3748 to 4299 1 to 552   tiling clone,   552/552
(100 %)
4 diff
(99.3 %id)
CK820327 insulinoma, Pancreas .a 3848 to 4149 1 to 302       302/302
(100 %)
5 diff
(98.4 %id)
TI_57164179   .a 3892 to 4607 29 to 745       717/745
(96 %)
6 diff
(99.2 %id)
BI836830 pooled pancreas and spleen .a 3896 to 4607 1 to 712       712/712
(100 %)
11 diff
(98.5 %id)
AK124683 amygdala .a 3956 to 6833 1 to 2878   available from FLJ,   2878/2878
(100 %)
1 diff
(100.0 %id)
DA184459 amygdala .a 3957 to 4512 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
W77869 heart .a 4008 to 4436 1 to 428       428/429
(99 %)
4 diff
(99.1 %id)
AY726577 testis .a 4036 to 6833 1 to 2798   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2798/2798
(100 %)
0 diff
(100 %id)
BQ685458 ductal carcinoma, cell line, Pancreas .a 4075 to 4932 10 to 873       864/873
(98 %)
6 diff
(99.4 %id)
BQ689289 ductal carcinoma, cell line, Pancreas .a 4075 to 4919 10 to 866       857/928
(92 %)
38 diff
(96.0 %id)
CN292342 embryonic stem cells, DMSO-treated H9 cellline .a 4185 to 4750 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BE302840 melanotic melanoma, skin .a 4194 to 4625 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
BE386408 melanotic melanoma, skin .a 4210 to 4929 1 to 718       718/743
(96 %)
23 diff
(97.0 %id)
BE275886 melanotic melanoma, skin .a 4211 to 4845 1 to 631       631/631
(100 %)
5 diff
(99.3 %id)
BE389203 endometrium, adenocarcinoma cell line, uterus .a 4211 to 4690 1 to 482       482/484
(99 %)
12 diff
(97.6 %id)
BE390351 endometrium, adenocarcinoma cell line, uterus .a 4211 to 4839 1 to 624       624/686
(90 %)
14 diff
(98.0 %id)
BF026146 melanotic melanoma, skin .a 4211 to 4871 1 to 656       656/656
(100 %)
5 diff
(99.3 %id)
DA262716 caudate nucleus .a 4221 to 4790 2 to 571   capped   570/571
(99 %)
1 diff
(99.9 %id)
BE409762 choriocarcinoma, placenta .a 4232 to 4868 103 to 756       654/756
(86 %)
6 diff
(99.3 %id)
DA078844 cerebellum .a 4296 to 4857 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
AA359173 lung .a 4325 to 4679 1 to 357       357/357
(100 %)
10 diff
(97.2 %id)
BF569446 Kidney, renal carcinoma (ascites) .a 4461 to 5114 1 to 639       639/905
(70 %)
16 diff
(98.3 %id)
BE019005 Kidney, renal cell adenocarcinoma .a 4588 to 4890 1 to 303       303/303
(100 %)
0 diff
(100 %id)
AW936990 denis_drash .a 4627 to 4813 187 to 1     Submitted on the opposite strand 187/217
(86 %)
6 diff
(97.3 %id)
DA683924   .a 4636 to 5217 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BG753324 eye, normal pigmented retinal epithelium .a 4672 to 5365 1 to 699       699/699
(100 %)
6 diff
(99.2 %id)
BQ327321 colon_normal .a 4748 to 5024 304 to 28       277/304
(91 %)
0 diff
(100 %id)
DA464086   .a 4750 to 5326 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BM710635 eye, fetal eyes .a 4864 to 5142 1 to 279       279/279
(100 %)
0 diff
(100 %id)
DA016538 adrenal gland .a 4901 to 5436 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
CD693161 normal nasopharynx .a 4947 to 5132 15 to 203       189/203
(93 %)
6 diff
(97.1 %id)
BX477913   .a 4948 to 5417 1 to 473       473/473
(100 %)
1 diff
(99.8 %id)
DN994772 brain, whole brain .a 4993 to 5727 9 to 747       739/747
(98 %)
3 diff
(99.6 %id)
BG676746 skin, squamous cell carcinoma .a 5016 to 5804 1 to 825       825/828
(99 %)
19 diff
(97.8 %id)
CD515305 White Matter .a 5041 to 5924 1 to 893       893/895
(99 %)
16 diff
(98.3 %id)
AF070582 brain .a 5092 to 6833 1 to 1744   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1744/1744
(100 %)
5 diff
(99.8 %id)
BG750919 eye, normal pigmented retinal epithelium .a 5112 to 5896 1 to 796       796/935
(85 %)
17 diff
(98.2 %id)
BQ641752 eye, normal pigmented retinal epithelium .a 5114 to 6046 1 to 942       942/942
(100 %)
12 diff
(98.8 %id)
BG749739 eye, normal pigmented retinal epithelium .a 5115 to 5861 3 to 749       747/749
(99 %)
6 diff
(99.2 %id)
DA380956 thalamus .a 5117 to 5667 2 to 556   capped   555/560
(99 %)
3 diff
(99.5 %id)
CV574718 cornea, eye .a 5136 to 5755 1 to 620       620/620
(100 %)
0 diff
(100 %id)
T80293 whole brain .a 5181 to 5419 1 to 242       242/242
(100 %)
3 diff
(98.8 %id)
BU178513 eye, retinoblastoma .a 5275 to 6170 1 to 901       901/901
(100 %)
13 diff
(98.6 %id)
BX433068 brain, fetal brain .a 5293 to 6149 858 to 4       855/979
(87 %)
0 diff
(100 %id)
W22942 eye, retina .a 5293 to 5841 562 to 16       547/566
(96 %)
0 diff
(100 %id)
BG328701 adenocarcinoma cell line, colon .a 5358 to 6085 1 to 720       720/720
(100 %)
8 diff
(98.9 %id)
AW365825 head_neck .a 5476 to 5944 1 to 470       470/470
(100 %)
13 diff
(97.3 %id)
AW178340 head_neck .a 5486 to 5934 1 to 449       449/450
(99 %)
4 diff
(99.2 %id)
AW365854 head_neck .a 5487 to 5977 1 to 489       489/489
(100 %)
5 diff
(99.0 %id)
AW365629 head_neck .a 5491 to 6082 10 to 598       589/598
(98 %)
6 diff
(99.0 %id)
H81100 liver and spleen .a 5498 to 5902 1 to 411       411/429
(95 %)
8 diff
(98.2 %id)
BX099232 liver and spleen .a 5499 to 6196 1 to 697       697/697
(100 %)
1 diff
(99.9 %id)
AW365725 head_neck .a 5500 to 5846 12 to 356       345/356
(96 %)
6 diff
(98.4 %id)
BC005078 Uterus, endometrium adenocarcinoma .a 5512 to 6833 1 to 1321   available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1321/1321
(100 %)
4 diff
(99.7 %id)
BE379464 endometrium, adenocarcinoma cell line, uterus .a 5512 to 6242 38 to 765   available from MGC,   728/766
(95 %)
6 diff
(99.3 %id)
AW351699 colon .a 5514 to 6101 1 to 589       589/593
(99 %)
7 diff
(98.9 %id)
BQ348629 head_neck .a 5520 to 6012 70 to 571       502/572
(87 %)
27 diff
(95.3 %id)
AW365781 head_neck .a 5522 to 5929 1 to 409       409/409
(100 %)
18 diff
(95.6 %id)
BC080559 Lymph, lymphoma .a 5530 to 6833 1 to 1304   available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1304/1304
(100 %)
1 diff
(100.0 %id)
BU147027 lymph, lymphoma, cell line .a 5530 to 6422 18 to 910   available from MGC,   893/944
(94 %)
25 diff
(97.4 %id)
BQ062218 lymph, lymphoma, cell line .a 5531 to 5891 1 to 368       368/1058
(34 %)
12 diff
(98.9 %id)
AW351686 colon .a 5541 to 6002 1 to 463       463/463
(100 %)
4 diff
(99.2 %id)
AW351676 colon .a 5557 to 6038 1 to 484       484/485
(99 %)
24 diff
(95.1 %id)
AW365769 head_neck .a 5569 to 5732 1 to 168       168/168
(100 %)
9 diff
(94.7 %id)
N64288 liver and spleen .a 5577 to 5947 1 to 373       373/373
(100 %)
2 diff
(99.5 %id)
BM549539 astrocytoma grade IV, cell line, brain .a 5586 to 6606 1 to 1034       1034/1195
(86 %)
6 diff
(99.5 %id)
BQ650131 hepatocellular carcinoma, cell line, Liver .a 5593 to 6522 1 to 941       941/971
(96 %)
36 diff
(96.3 %id)
BQ651270 hepatocellular carcinoma, cell line, Liver .a 5593 to 6356 1 to 768       768/923
(83 %)
26 diff
(97.2 %id)
R54533 whole brain .a 5607 to 6084 1 to 487     Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 487/487
(100 %)
15 diff
(97.0 %id)
H10605 whole brain .a 5607 to 6069 1 to 477       477/481
(99 %)
20 diff
(95.9 %id)
BG749251 eye, normal pigmented retinal epithelium .a 5634 to 6384 1 to 751       751/751
(100 %)
13 diff
(98.3 %id)
BG750156 eye, normal pigmented retinal epithelium .a 5634 to 6496 1 to 862       862/894
(96 %)
23 diff
(97.5 %id)
BM914373 Spleen .a 5670 to 6224 1 to 555       555/1070
(51 %)
26 diff
(97.6 %id)
BX433067 brain, fetal brain .a 5696 to 6144 446 to 1       446/453
(98 %)
5 diff
(98.9 %id)
AL050001 brain .a 5700 to 6834 1 to 1135   available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1135/1136
(99 %)
5 diff
(99.6 %id)
BG759637 B-cells, primary B-cells from tonsils (cell line) .a 5706 to 6443 1 to 738       738/850
(86 %)
8 diff
(99.1 %id)
BF374438 stomach .a 5736 to 6270 542 to 3       540/544
(99 %)
0 diff
(100 %id)
AW366127 head_neck .a 5740 to 6184 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AW375371 colon .a 5742 to 6288 559 to 12       548/559
(98 %)
0 diff
(100 %id)
AW375336 colon .a 5753 to 6288 544 to 10       535/544
(98 %)
0 diff
(100 %id)
AL534312 brain, fetal brain .a 5804 to 6772 989 to 37       953/1050
(90 %)
0 diff
(100 %id)
CF126425 Chondrosarcoma Lung Metastasis cell lines, lung .a 5836 to 6555 1 to 718       718/718
(100 %)
7 diff
(99.1 %id)
TI_154189413   .a 5836 to 6705 51 to 908       858/1003
(85 %)
24 diff
(97.7 %id)
TI_149300641   .a 5881 to 6833 1011 to 87   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 925/985
(93 %)
13 diff
(98.7 %id)
BM043057 carcinoma, cell line, Prostate .a 5900 to 6479 1 to 601       601/770
(78 %)
51 diff
(93.4 %id)
BM045715 carcinoma, cell line, Prostate .a 5901 to 6540 1 to 638       638/638
(100 %)
11 diff
(98.3 %id)
BQ347343 head_neck .a 5904 to 6200 1 to 298       298/298
(100 %)
15 diff
(95.0 %id)
CR590543 fetal brain .a 5913 to 6827 1 to 915       915/915
(100 %)
0 diff
(100 %id)
BX419998 brain, fetal brain .a 5913 to 6835 1 to 920   fully sequenced,   920/920
(100 %)
7 diff
(99.3 %id)
BM193986 leukopheresis .a 5917 to 6504 589 to 1       589/589
(100 %)
10 diff
(98.4 %id)
AW752120 colon .a 5965 to 6184 220 to 1       220/220
(100 %)
10 diff
(95.5 %id)
TI_149311707   .a 5981 to 6833 934 to 92   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 843/934
(90 %)
19 diff
(98.0 %id)
BM263098 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 6047 to 6593 11 to 556       546/556
(98 %)
6 diff
(99.0 %id)
BU618514 Cell Line, Chondrosarcoma .a 6055 to 6679 1 to 625     Submitted on the opposite strand 625/625
(100 %)
3 diff
(99.6 %id)
CN366131 embryonic stem cells, DMSO-treated H9 cellline .a 6059 to 6677 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
TI_149309452   .a 6062 to 6833 871 to 103   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 769/950
(80 %)
6 diff
(99.4 %id)
BE244641 leukopheresis .a 6063 to 6504 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
TI_149312018   .a 6063 to 6833 852 to 83   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 770/934
(82 %)
4 diff
(99.6 %id)
BG149934 carcinoid, lung .a 6066 to 6517 1 to 451     Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
AW752132 colon .a 6073 to 6267 197 to 4       194/200
(97 %)
0 diff
(100 %id)
BM152916 leukopheresis .a 6080 to 6504 426 to 1       426/428
(99 %)
6 diff
(98.6 %id)
AW375335 colon .a 6092 to 6283 191 to 1       191/191
(100 %)
11 diff
(94.3 %id)
BM977745 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 6098 to 6833 753 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 735/735
(100 %)
4 diff
(99.5 %id)
CB529798 Aveolar Macrophage, lung .a 6102 to 6833 749 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 731/731
(100 %)
3 diff
(99.6 %id)
BU633676 cell lines, Chondrosarcoma .a 6104 to 6833 746 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 728/728
(100 %)
4 diff
(99.5 %id)
AA304565 aorta .a 6105 to 6409 1 to 308       308/313
(98 %)
5 diff
(98.5 %id)
TI_149305633   .a 6112 to 6921 892 to 92   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 801/967
(82 %)
13 diff
(98.7 %id)
BM976668 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 6114 to 6833 736 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 718/720
(99 %)
3 diff
(99.6 %id)
AA385300 thyroid gland .a 6117 to 6497 1 to 384       384/384
(100 %)
5 diff
(98.7 %id)
BQ018774 lung, Metastatic Chondrosarcoma .a 6123 to 6833 728 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 710/717
(99 %)
5 diff
(99.4 %id)
BG253283 adenocarcinoma, cell line, Liver .a 6125 to 6902 1 to 764       764/936
(81 %)
27 diff
(97.2 %id)
TI_149313881   .a 6129 to 6833 815 to 112   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 704/946
(74 %)
9 diff
(99.1 %id)
BM977488 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 6133 to 6833 719 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 701/701
(100 %)
2 diff
(99.8 %id)
BQ187481 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6137 to 6801 1 to 665   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 665/665
(100 %)
3 diff
(99.6 %id)
BQ185786 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6137 to 6818 1 to 679   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 679/679
(100 %)
6 diff
(99.2 %id)
TI_151763926   .a 6137 to 6826 794 to 109   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 686/907
(75 %)
6 diff
(99.4 %id)
BF570092 Kidney, renal carcinoma (ascites) .a 6154 to 6873 759 to 38       722/1127
(64 %)
0 diff
(100 %id)
CD370883 Alveolar Macrophage, lung .a 6156 to 6833 695 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 677/677
(100 %)
3 diff
(99.6 %id)
AW978173   .a 6161 to 6832 674 to 1     Submitted on the opposite strand 674/678
(99 %)
20 diff
(97.1 %id)
AV751539 Pituitary .a 6176 to 6406 1 to 223       223/223
(100 %)
8 diff
(96.5 %id)
TI_149286598   .a 6181 to 6921 815 to 80   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 736/800
(92 %)
8 diff
(99.0 %id)
BU619050 Cell Line, Chondrosarcoma .a 6183 to 6833 668 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 650/650
(100 %)
2 diff
(99.7 %id)
CA306714 Alveolar Macrophage, lung .a 6183 to 6826 661 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
BQ446970 Knee, Osteoarthritic Cartilage .a 6184 to 6833 667 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
BM053032 Islets of Langerhans, Pancreas .a 6192 to 6555 1 to 364   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 364/364
(100 %)
1 diff
(99.8 %id)
BU687844 lung .a 6195 to 6833 657 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 639/639
(100 %)
3 diff
(99.6 %id)
CB851607 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 6195 to 6833 657 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 639/639
(100 %)
6 diff
(99.1 %id)
BU685956 lung, Primary Lung Epithelial Cells .a 6197 to 6921 740 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 722/722
(100 %)
4 diff
(99.5 %id)
BQ020549 Fibrosarcoma .a 6201 to 6833 650 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 632/632
(100 %)
5 diff
(99.3 %id)
TI_149287215   .a 6204 to 6921 795 to 86   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 710/710
(100 %)
15 diff
(97.9 %id)
CA428815 Cell Line, Chondrosarcoma .a 6208 to 6833 645 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 627/627
(100 %)
1 diff
(99.9 %id)
BU629976 cell lines, Chondrosarcoma .a 6208 to 6833 644 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 626/626
(100 %)
4 diff
(99.4 %id)
BM972138 lung .a 6231 to 6921 707 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 689/689
(100 %)
4 diff
(99.5 %id)
AI968222 pooled germ cell tumors .a 6233 to 6835 606 to 4       603/606
(99 %)
0 diff
(100 %id)
BF057074 pooled germ cell tumors .a 6233 to 6830 599 to 1       599/599
(100 %)
2 diff
(99.7 %id)
BQ614101 insulinoma, Pancreas .a 6233 to 6833 622 to 21   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 602/602
(100 %)
1 diff
(99.9 %id)
BM972566 lung .a 6249 to 6921 690 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 672/688
(97 %)
2 diff
(99.8 %id)
AW519129 adenocarcinoma, Pancreas .a 6252 to 6834 583 to 1       583/583
(100 %)
0 diff
(100 %id)
BU621185 cell lines, Chondrosarcoma .a 6280 to 6927 667 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
AA767355 germinal center B cell .a 6284 to 6833 561 to 12   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 550/550
(100 %)
1 diff
(99.9 %id)
AI829892 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 6286 to 6834 549 to 1       549/551
(99 %)
3 diff
(99.5 %id)
DB303062 amygdala .a 6291 to 6833 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
AI818939 lymph node, lymphoma, follicular mixed small and largecell .a 6309 to 6826 518 to 1       518/518
(100 %)
1 diff
(99.9 %id)
N58072 liver and spleen .a 6320 to 6833 522 to 1       522/523
(99 %)
14 diff
(97.4 %id)
TI_151710714   .a 6323 to 6833 630 to 116   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 515/1056
(48 %)
21 diff
(98.1 %id)
CB046660 2 pooled tumors (clear cell type), Kidney .a 6336 to 6404 10 to 77   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 68/77
(88 %)
6 diff
(92.3 %id)
AI433397 Kidney .a 6339 to 6833 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AI818957 lymph node, lymphoma, follicular mixed small and largecell .a 6339 to 6826 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BM142670 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 6343 to 6835 494 to 2       493/494
(99 %)
0 diff
(100 %id)
BE671918 pooled germ cell tumors .a 6349 to 6835 490 to 4       487/490
(99 %)
0 diff
(100 %id)
AI819954 lymph node, lymphoma, follicular mixed small and largecell .a 6350 to 6826 477 to 1       477/477
(100 %)
0 diff
(100 %id)
W72086 heart .a 6360 to 6835 489 to 7       483/491
(98 %)
0 diff
(100 %id)
AI338015 uterus .a 6360 to 6840 487 to 14   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 474/474
(100 %)
9 diff
(98.2 %id)
N71867 cochlea, ear .a 6361 to 6833 500 to 25   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 476/476
(100 %)
6 diff
(98.8 %id)
AW044306 thymus, pooled .a 6361 to 6833 473 to 1       473/473
(100 %)
9 diff
(98.1 %id)
AI769474 2 pooled tumors (clear cell type), Kidney .a 6383 to 6927 555 to 11   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 545/545
(100 %)
5 diff
(99.1 %id)
AI375693   .a 6393 to 6833 455 to 15   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 441/441
(100 %)
1 diff
(99.8 %id)
AI379510 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6393 to 6833 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AA703071 liver and spleen .a 6397 to 6833 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI379089 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6397 to 6833 453 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 437/437
(100 %)
0 diff
(100 %id)
CK820326 insulinoma, Pancreas .a 6399 to 6833 456 to 22   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 435/435
(100 %)
0 diff
(100 %id)
CB046659 2 pooled tumors (clear cell type), Kidney .a 6402 to 6826 454 to 30   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 425/425
(100 %)
4 diff
(99.1 %id)
AA836155 germinal center B cell .a 6403 to 6833 451 to 21   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
BE206693 Kidney, renal cell adenocarcinoma .a 6412 to 6835 425 to 2       424/425
(99 %)
0 diff
(100 %id)
R49578 whole brain .a 6414 to 6833 436 to 12   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 425/425
(100 %)
8 diff
(98.2 %id)
AI090082 uterus .a 6414 to 6835 423 to 2       422/423
(99 %)
0 diff
(100 %id)
BX435279 brain, fetal brain .a 6422 to 6827 402 to 1   fully sequenced,   402/402
(100 %)
5 diff
(98.8 %id)
BU161601 melanotic melanoma, skin .a 6428 to 6833 1 to 406   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 406/406
(100 %)
0 diff
(100 %id)
H10397 whole brain .a 6429 to 6835 439 to 23       417/442
(94 %)
0 diff
(100 %id)
H81101 liver and spleen .a 6429 to 6811 384 to 1       384/387
(99 %)
2 diff
(99.5 %id)
AA749394 germinal center B cell .a 6430 to 6833 426 to 23   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
BF940983 brain, oligodendroglioma .a 6430 to 6833 422 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 404/404
(100 %)
3 diff
(99.3 %id)
AW193970 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6432 to 6824 393 to 1       393/393
(100 %)
8 diff
(98.0 %id)
AI380857 B-cell, chronic lymphotic leukemia .a 6434 to 6834 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AW003422 normal epithelium, ovary .a 6435 to 6921 508 to 23   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 486/486
(100 %)
8 diff
(98.4 %id)
AA814941 germinal center B cell .a 6444 to 6833 410 to 21   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 390/390
(100 %)
4 diff
(99.0 %id)
BM992889 lung, Metastatic Chondrosarcoma .a 6446 to 6833 406 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AW275282 brain, three pooled meningiomas .a 6452 to 6923 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
AI167492 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6463 to 6833 392 to 22   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 371/371
(100 %)
0 diff
(100 %id)
AI476544 colon, moderately-differentiated adenocarcinoma .a 6466 to 6833 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AW302185 Kidney .a 6476 to 6925 450 to 1       450/450
(100 %)
2 diff
(99.6 %id)
N70481 lung .a 6482 to 6921 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
AI124007 uterus .a 6484 to 6923 440 to 1       440/440
(100 %)
0 diff
(100 %id)
R54436 whole brain .a 6492 to 6833 373 to 24   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 350/384
(91 %)
11 diff
(97.2 %id)
BQ185542 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6492 to 6826 352 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 334/334
(100 %)
1 diff
(99.8 %id)
CN478540 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6501 to 6826 344 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 326/326
(100 %)
0 diff
(100 %id)
AI208432   .a 6504 to 6924 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI282524 Kidney, renal cell tumor .a 6504 to 6835 332 to 1       332/332
(100 %)
0 diff
(100 %id)
C21227   .a 6507 to 6817 1 to 313       313/336
(93 %)
8 diff
(97.7 %id)
AI632022 Kidney .a 6523 to 6834 312 to 1       312/312
(100 %)
17 diff
(94.6 %id)
BM052737 Islets of Langerhans, Pancreas .a 6525 to 6833 333 to 25   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 309/309
(100 %)
2 diff
(99.4 %id)
CB177478 Pancreas, Purified pancreatic islet .a 6529 to 6833 16 to 320   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 305/320
(95 %)
6 diff
(98.2 %id)
AI392729 B-cell, chronic lymphotic leukemia .a 6531 to 6835 312 to 8       305/312
(97 %)
0 diff
(100 %id)
AA720610 germinal center B cell .a 6532 to 6833 318 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 302/302
(100 %)
0 diff
(100 %id)
AA700405 liver and spleen .a 6540 to 6833 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AI580313 Kidney .a 6544 to 6922 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AA916316 pooled .a 6546 to 6923 379 to 1       379/379
(100 %)
3 diff
(99.3 %id)
AI868572 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6546 to 6823 306 to 29   AAA   278/288
(96 %)
0 diff
(100 %id)
BF914020 uterus_tumor .a 6561 to 6803 302 to 58     Submitted on the opposite strand 245/302
(81 %)
0 diff
(100 %id)
CB177858 Pancreas, Purified pancreatic islet .a 6567 to 6837 271 to 1   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 271/271
(100 %)
2 diff
(99.3 %id)
BF509351   .a 6570 to 6921 369 to 18   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 352/358
(98 %)
0 diff
(100 %id)
EH346959   .a 6573 to 6625 1 to 53       53/53
(100 %)
0 diff
(100 %id)
FN071094 breast carcinoma .a 6573 to 6662 1 to 89       89/89
(100 %)
1 diff
(98.9 %id)
AI401641 Prostate .a 6604 to 6925 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AI810298 Prostate .a 6605 to 6925 324 to 4       321/324
(99 %)
0 diff
(100 %id)
BE645659 Prostate .a 6605 to 6925 323 to 3       321/323
(99 %)
0 diff
(100 %id)
BF221678 Prostate .a 6605 to 6925 323 to 3       321/323
(99 %)
0 diff
(100 %id)
BQ227455 melanotic melanoma, skin .a 6605 to 6833 7 to 235   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 229/235
(97 %)
6 diff
(97.5 %id)
FN062984 breast carcinoma .a 6692 to 6799 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AI923890 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6718 to 6833 132 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 116/116
(100 %)
2 diff
(98.3 %id)
AI758853 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6788 to 6923 136 to 1       382/409
(93 %)
11 diff
(97.4 %id)
AK309040 hippocampus .b 1 to 2002 1 to 2002 exact tiling clone,   2002/2002
(100 %)
0 diff
(100 %id)
BX116734 pooled .b 1431 to 1908 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
AA504256 germinal center B cell .b 1872 to 2393 522 to 1   tiling clone,   522/522
(100 %)
1 diff
(99.9 %id)
BU753188 placenta .b 1881 to 2384 520 to 18   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 503/503
(100 %)
2 diff
(99.7 %id)
AI740465 pooled .b 1905 to 2390 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AA835881 germinal center B cell .b 1941 to 2393 453 to 1   tiling clone,   453/453
(100 %)
4 diff
(99.2 %id)
AI375224 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1977 to 2384 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
AA766391 germinal center B cell .b 1994 to 2315 324 to 1       324/324
(100 %)
15 diff
(95.4 %id)
DB093937 testis .c 1 to 551 2 to 553   tiling clone, capped   552/552
(100 %)
2 diff
(99.7 %id)
BX415712 thymus .c 470 to 1316 1 to 845   tiling clone,   845/845
(100 %)
3 diff
(99.7 %id)
BX415711 thymus .c 1368 to 2268 903 to 1   tiling clone,   903/903
(100 %)
2 diff
(99.8 %id)
BP278294   .d 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
BX415463 thymus .e 1 to 846 1 to 847 I9X H24A R25P K26Q I27D ... tiling clone,   847/851
(99 %)
5 diff
(99.5 %id)
CB046148 2 pooled tumors (clear cell type), Kidney .e 2637 to 3282 1 to 648   tiling clone, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 648/648
(100 %)
8 diff
(98.8 %id)
BX415462 thymus .e 3484 to 4357 876 to 1   tiling clone,   876/876
(100 %)
5 diff
(99.5 %id)
CB046147 2 pooled tumors (clear cell type), Kidney .e 5026 to 5669 686 to 45   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 642/642
(100 %)
11 diff
(98.3 %id)
BF946547 nervous_normal .f-u 1 to 358 1 to 358 C24W Q32E V93G V96G F99V tiling clone,   358/358
(100 %)
7 diff
(98.1 %id)
BF895071 marrow .g 1 to 422 1 to 423 R2G F6L H8D H15Y P16I ... tiling clone,   423/424
(99 %)
18 diff
(95.8 %id)
AI394391 pooled .h 1 to 399 1 to 399   tiling clone, Submitted on the opposite strand 399/399
(100 %)
6 diff
(98.5 %id)
AA421067   .h 52 to 503 1 to 451   tiling clone,   451/451
(100 %)
1 diff
(99.8 %id)
BE830755 marrow .h 109 to 369 265 to 1       265/271
(97 %)
14 diff
(94.9 %id)
AW292085   .h 223 to 395 194 to 22       173/194
(89 %)
0 diff
(100 %id)
BF334904 colon .h 227 to 421 1 to 195   tiling clone,   195/195
(100 %)
2 diff
(99.0 %id)
AA420987   .h 954 to 1312 362 to 4   tiling clone,   359/362
(99 %)
0 diff
(100 %id)
BF953199 nervous_normal .i 30 to 257 54 to 280 E2K A3P K4R T6R L7* tiling clone,   273/280
(97 %)
7 diff
(97.5 %id)
BE159816 head_neck .j-u 1 to 385 18 to 402 V19G M20V S21W D39G tiling clone,   385/402
(95 %)
9 diff
(97.8 %id)
BF957550 nervous_normal .k-u 1 to 283 22 to 300 A2R I3V R8K H10Q V11* tiling clone,   279/300
(93 %)
10 diff
(96.7 %id)
AI470796 Kidney .l 1 to 282 282 to 1 exact tiling clone,   282/282
(100 %)
1 diff
(99.7 %id)
BF381086 uterus_tumor Gene CCDC93, variant not shown              
BF381097 uterus_tumor Gene CCDC93, variant not shown              
BG104238 melanotic melanoma, skin Gene CCDC93, variant not shown         Suspected internal deletion, this clone was ignored    
BM459047 melanotic melanoma, skin Gene CCDC93, variant not shown         Suspected internal deletion, this clone was ignored    
DB322455   Gene CCDC93, variant not shown              
DA677508   Gene CCDC93, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j-u, .k-u, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C